Royalty Payments. 3.1.1. In partial consideration for the rights and licenses granted pursuant to Section 2.1 (Grant of Rights), Licensee shall pay to Licensor royalties equal to five percent (5%) of the Net Sales of any Licensed Products in a Quarter.
Appears in 13 contracts
Sources: License Agreement (Regen BioPharma Inc), License Agreement (Regen BioPharma Inc), License Agreement (Regen BioPharma Inc)
Royalty Payments. 3.1.13.3.1. In partial consideration for the rights and licenses granted pursuant to Section 2.1 (Grant of Rights), Licensee shall pay to Licensor royalties equal to five four percent (54%) of the Net Sales of any Licensed Products in a Quarter.
Appears in 7 contracts
Sources: License Agreement (Regen BioPharma Inc), License Agreement (Regen BioPharma Inc), License Agreement (Regen BioPharma Inc)